Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2012

Open Access 01-02-2012 | Research article

Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies

Authors: Chih Long Liu, Stephanie Tangsombatvisit, Jacob M Rosenberg, Gil Mandelbaum, Emily C Gillespie, Or P Gozani, Ash A Alizadeh, Paul J Utz

Published in: Arthritis Research & Therapy | Issue 1/2012

Login to get access

Abstract

Introduction

Autoreactivity to histones is a pervasive feature of several human autoimmune disorders, including systemic lupus erythematosus (SLE). Specific post-translational modifications (PTMs) of histones within neutrophil extracellular traps (NETs) may potentially drive the process by which tolerance to these chromatin-associated proteins is broken. We hypothesized that NETs and their unique histone PTMs might be capable of inducing autoantibodies that target histones.

Methods

We developed a novel and efficient method for the in vitro production, visualization, and broad profiling of histone-PTMs of human and murine NETs. We also immunized Balb/c mice with murine NETs and profiled their sera on autoantigen and histone peptide microarrays for evidence of autoantibody production to their immunogen.

Results

We confirmed specificity toward acetyl-modified histone H2B as well as to other histone PTMs in sera from patients with SLE known to have autoreactivity against histones. We observed enrichment for distinctive histone marks of transcriptionally silent DNA during NETosis triggered by diverse stimuli. However, NETs derived from human and murine sources did not harbor many of the PTMs toward which autoreactivity was observed in patients with SLE or in MRL/lpr mice. Further, while murine NETs were weak autoantigens in vivo, there was only partial overlap in the immunoglobulin G (IgG) and IgM autoantibody profiles induced by vaccination of mice with NETs and those seen in patients with SLE.

Conclusions

Isolated in vivo exposure to NETs is insufficient to break tolerance and may involve additional factors that have yet to be identified.
Appendix
Available only for authorised users
Literature
1.
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A: Neutrophil extracellular traps kill bacteria. Science. 2004, 303: 1532-1535. 10.1126/science.1092385.CrossRefPubMed
2.
Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann V, Zychlinsky A: Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007, 176: 231-241. 10.1083/jcb.200606027.PubMedCentralCrossRefPubMed
3.
Baker VS, Imade GE, Molta NB, Tawde P, Pam SD, Obadofin MO, Sagay SA, Egah DZ, Iya D, Afolabi BB, Baker M, Ford K, Ford R, Roux KH, Keller TC: Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age. Malar J. 2008, 7: 41-10.1186/1475-2875-7-41.PubMedCentralCrossRefPubMed
4.
Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A: Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Nat Acad Sci USA. 2010, 107: 9813-9818. 10.1073/pnas.0909927107.PubMedCentralCrossRefPubMed
5.
Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V: Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med. 2011, 3: 73ra20-10.1126/scitranslmed.3001201.PubMedCentralCrossRefPubMed
6.
Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, Meller S, Chamilos G, Sebasigari R, Riccieri V, Bassett R, Amuro H, Fukuhara S, Ito T, Liu YJ, Gilliet M: Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med. 2011, 3: 73ra19-10.1126/scitranslmed.3001180.PubMedCentralCrossRefPubMed
7.
Yung RL, Johnson KJ, Richardson BC: New concepts in the pathogenesis of drug-induced lupus. Lab invest. 1995, 73: 746-759.PubMed
8.
Hess E: Drug-Related Lupus. N Eng J Med. 1988, 318: 1460-1462. 10.1056/NEJM198806023182209.CrossRef
9.
Cervera R, Khamashta M, Font J, Sebastiani G, Gil A, Lavilla P, Doménech I, Aydintug A, Jedryka-Góral A, de Ramón E: Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine. 1993, 72: 113-124.CrossRefPubMed
10.
Schett G, Smolen J, Zimmermann C, Hiesberger H, Hoefler E, Fournel S, Muller S, Rubin R, Steiner G: The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity. Lupus. 2002, 11: 704-715. 10.1191/0961203302lu247oa.CrossRefPubMed
11.
Burlingame RW, Rubin RL: Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J Clin Invest. 1991, 88: 680-690. 10.1172/JCI115353.PubMedCentralCrossRefPubMed
12.
Rubin RL, Bell SA, Burlingame RW: Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. The Journal of Clinical Investigation. 1992, 90: 165-173. 10.1172/JCI115832.PubMedCentralCrossRefPubMed
13.
Totoritis MC, Tan EM, McNally EM, Rubin RL: Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. N Eng J Med. 1988, 318: 1431-1436. 10.1056/NEJM198806023182204.CrossRef
14.
Clark DWJ: Genetically determined variability in acetylation and oxidation therapeutic implications. Drugs. 1985, 29: 342-375. 10.2165/00003495-198529040-00003.CrossRefPubMed
15.
Woosley RL, Drayer DE, Reidenberg MM, Nies AS, Carr K, Oates JA: Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the Lupus Syndrome. N Eng Jf Med. 1978, 298: 1157-1159. 10.1056/NEJM197805252982101.CrossRef
16.
Jiang X, Khursigara G, Rubin R: Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science. 1994, 266: 810-813. 10.1126/science.7973636.CrossRefPubMed
17.
Utz PJ, Anderson P: Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum. 1998, 41: 1152-1160. 10.1002/1529-0131(199807)41:7<1152::AID-ART3>3.0.CO;2-L.CrossRefPubMed
18.
Satoh M, Kumar A, Kanwar YS, Reeves WH: Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci USA. 1995, 92: 10934-10938. 10.1073/pnas.92.24.10934.PubMedCentralCrossRefPubMed
19.
Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994, 179: 1317-1330. 10.1084/jem.179.4.1317.CrossRefPubMed
20.
Rosen A, Casciola-Rosen L: Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 1999, 6: 6-12. 10.1038/sj.cdd.4400460.CrossRefPubMed
21.
Greidinger EL, Casciola-Rosen L, Morris SM, Hoffman RW, Rosen A: Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations. Arthritis Rheum. 2000, 43: 881-888. 10.1002/1529-0131(200004)43:4<881::AID-ANR20>3.0.CO;2-G.CrossRefPubMed
22.
Mevorach D, Zhou JL, Song X, Elkon KB: Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med. 1998, 188: 387-392. 10.1084/jem.188.2.387.PubMedCentralCrossRefPubMed
23.
Gensler TJ, Hottelet M, Zhang C, Schlossman S, Anderson P, Utz PJ: Monoclonal antibodies derived from BALB/c mice immunized with apoptotic Jurkat T cells recognize known autoantigens. J Autoimmun. 2001, 16: 59-69. 10.1006/jaut.2000.0464.CrossRefPubMed
24.
Kamachi M, Le TM, Kim SJ, Geiger ME, Anderson P, Utz PJ: Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway. J Exp Med. 2002, 196: 1213-1225. 10.1084/jem.20021167.PubMedCentralCrossRefPubMed
25.
Neugebauer KM, Merrill JT, Wener MH, Lahita RG, Roth MB: SR proteins are autoantigens in patients with systemic lupus erythematosus. Importance of phosphoepitopes. Arthritis Rheum. 2000, 43: 1768-1778. 10.1002/1529-0131(200008)43:8<1768::AID-ANR13>3.0.CO;2-9.CrossRefPubMed
26.
Hill JA, Bell DA, Brintnell W, Yue D, Wehrli B, Jevnikar AM, Lee DM, Hueber W, Robinson WH, Cairns E: Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med. 2008, 205: 967-979. 10.1084/jem.20072051.PubMedCentralCrossRefPubMed
27.
Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998, 101: 273-281. 10.1172/JCI1316.PubMedCentralCrossRefPubMed
28.
van Bavel CC, Dieker J, Muller S, Briand JP, Monestier M, Berden JH, van der Vlag J: Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. Mol Immunol. 2009, 47: 511-516. 10.1016/j.molimm.2009.08.009.CrossRefPubMed
29.
Dieker JW, Fransen JH, van Bavel CC, Briand JP, Jacobs CW, Muller S, Berden JH, van der Vlag J: Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum. 2007, 56: 1921-1933. 10.1002/art.22646.CrossRefPubMed
30.
van Bavel CC, Dieker JW, Kroeze Y, Tamboer WP, Voll R, Muller S, Berden JH, van der Vlag J: Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus. Ann Rheum Dis. 2011, 70: 201-207. 10.1136/ard.2010.129320.CrossRefPubMed
31.
Wang Y, Li M, Stadler S, Correll S, Li P, Wang D, Hayama R, Leonelli L, Han H, Grigoryev SA, Allis CD, Coonrod SA: Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol. 2009, 184: 205-213. 10.1083/jcb.200806072.PubMedCentralCrossRefPubMed
32.
Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, Sonbuchner LS, McDonald CH, Cook RG, Dou Y, Roeder RG, Clarke S, Stallcup MR, Allis CD, Coonrod SA: Human PAD4 regulates histone arginine methylation levels via demethylimination. Science. 2004, 306: 279-283. 10.1126/science.1101400.CrossRefPubMed
33.
Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y: PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010, 207: 1853-1862. 10.1084/jem.20100239.PubMedCentralCrossRefPubMed
34.
Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, Brinkmann V, Jungblut PR, Zychlinsky A: Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 2009, 5: e1000639-10.1371/journal.ppat.1000639.PubMedCentralCrossRefPubMed
35.
Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, Dean EJ, Fournel S, Fong D, Genovese MC, de Vegvar HE, Skriner K, Hirschberg DL, Morris RI, Muller S, Pruijn GJ, van Venrooij WJ, Smolen JS, Brown PO, Steinman L, Utz PJ: Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med. 2002, 8: 295-301. 10.1038/nm0302-295.CrossRefPubMed
36.
Bua DJ, Kuo AJ, Cheung P, Liu CL, Migliori V, Espejo A, Casadio F, Bassi C, Amati B, Bedford MT, Guccione E, Gozani O: Epigenome microarray platform for proteome-wide dissection of chromatin-signaling networks. PLoS One. 2009, 4: e6789-10.1371/journal.pone.0006789.PubMedCentralCrossRefPubMed
37.
Noya O, Alarcon de Noya B: The multiple antigen blot assay (MABA): a simple immunoenzymatic technique for simultaneous screening of multiple antigens. Immunol Lett. 1998, 63: 53-56. 10.1016/S0165-2478(98)00055-8.CrossRefPubMed
38.
Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, Behrens TW: Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA. 2003, 100: 2610-2615. 10.1073/pnas.0337679100.PubMedCentralCrossRefPubMed
39.
Bauer JW, Petri M, Batliwalla FM, Koeuth T, Wilson J, Slattery C, Panoskaltsis-Mortari A, Gregersen PK, Behrens TW, Baechler EC: Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study. Arthritis Rheum. 2009, 60: 3098-3107. 10.1002/art.24803.PubMedCentralCrossRefPubMed
40.
Petri M, Singh S, Tesfasyone H, Dedrick R, Fry K, Lal P, Williams G, Bauer J, Gregersen P, Behrens T, Baechler E: Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus. 2009, 18: 980-989. 10.1177/0961203309105529.CrossRefPubMed
41.
Gallo RL, Kim KJ, Bernfield M, Kozak CA, Zanetti M, Merluzzi L, Gennaro R: Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem. 1997, 272: 13088-13093. 10.1074/jbc.272.20.13088.CrossRefPubMed
42.
Gaines P, Berliner N: Differentiation and characterization of myeloid cells. Curr Protoc Immunol. 2005, Chapter 22: Unit 22F 25
43.
Tsai S, Collins SJ: A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Nat Acad Sci USA. 1993, 90: 7153-7157. 10.1073/pnas.90.15.7153.PubMedCentralCrossRefPubMed
44.
Brinkmann V, Laube B, Abu Abed U, Goosmann C, Zychlinsky A: Neutrophil extracellular traps: how to generate and visualize them. J Vis Exp. 2010, piii 1724-36
45.
von Kockritz-Blickwede M, Chow OA, Nizet V: Fetal calf serum contains heat-stable nucleases that degrade neutrophil extracellular traps. Blood. 2009, 114: 5245-5246. 10.1182/blood-2009-08-240713.PubMedCentralCrossRefPubMed
46.
Baslund B, Wieslander J: A rapid and semi-quantitative method for the detection of autoantibodies by multiple spot immunoassay. J Immunol Methods. 1994, 169: 183-193. 10.1016/0022-1759(94)90262-3.CrossRefPubMed
47.
Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001, 98: 5116-5121. 10.1073/pnas.091062498.PubMedCentralCrossRefPubMed
48.
Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998, 95: 14863-14868. 10.1073/pnas.95.25.14863.PubMedCentralCrossRefPubMed
49.
Saldanha AJ: Java Treeview--extensible visualization of microarray data. Bioinformatics. 2004, 20: 3246-3248. 10.1093/bioinformatics/bth349.CrossRefPubMed
50.
51.
Garcia BA, Busby SA, Shabanowitz J, Hunt DF, Mishra N: Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. J Proteome Res. 2005, 4: 2032-2042. 10.1021/pr050188r.CrossRefPubMed
52.
Burlingame R, Boey M, Starkebaum G, Rubin R: The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest. 1994, 94: 184-10.1172/JCI117305.PubMedCentralCrossRefPubMed
53.
Jenuwein T, Allis CD: Translating the histone code. Science. 2001, 293: 1074-1080. 10.1126/science.1063127.CrossRefPubMed
54.
Thibault DL, Chu AD, Graham KL, Balboni I, Lee LY, Kohlmoos C, Landrigan A, Higgins JP, Tibshirani R, Utz PJ: IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J Clin Invest. 2008, 118: 1417-1426. 10.1172/JCI30065.PubMedCentralCrossRefPubMed
55.
Neeli I, Khan SN, Radic M: Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol. 2008, 180: 1895-1902.CrossRefPubMed
56.
Grunstein M: Histone acetylation in chromatin structure and transcription. Nature. 1997, 389: 349-352. 10.1038/38664.CrossRefPubMed
57.
Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, Rubin CJ, Zhao W, Olsen SH, Klinker M, Shealy D, Denny MF, Plumas J, Chaperot L, Kretzler M, Bruce AT, Kaplan MJ: Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol. 2011, 187: 538-552. 10.4049/jimmunol.1100450.PubMedCentralCrossRefPubMed
58.
Mishra N, Reilly CM, Brown DR, Ruiz P, Gilkeson GS: Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest. 2003, 111: 539-552.PubMedCentralCrossRefPubMed
59.
Hu N, Qiu X, Luo Y, Yuan J, Li Y, Lei W, Zhang G, Zhou Y, Su Y, Lu Q: Abnormal histone modification patterns in lupus CD4+ T cells. J Rheumatol. 2008, 35: 804-810.PubMed
60.
Forster N, Gallinat S, Jablonska J, Weiss S, Elsasser HP, Lutz W: p300 protein acetyltransferase activity suppresses systemic lupus erythematosus-like autoimmune disease in mice. J Immunol. 2007, 178: 6941-6948.CrossRefPubMed
61.
Shoshan Y, Mevorach D: Accelerated autoimmune disease in MRL/MpJ-Fas(lpr) but not in MRL/MpJ following immunization with high load of syngeneic late apoptotic cells. Autoimmunity. 2004, 37: 103-109. 10.1080/08916930410001666622.CrossRefPubMed
62.
Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, Grone HJ, Brinkmann V, Jenne DE: Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009, 15: 623-625. 10.1038/nm.1959.PubMedCentralCrossRefPubMed
63.
Katz U, Zandman-Goddard G: Drug-induced lupus: an update. Autoimmun Rev. 2010, 10: 46-50. 10.1016/j.autrev.2010.07.005.CrossRefPubMed
64.
Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT: Extracellular histones are major mediators of death in sepsis. Nat Med. 2009, 15: 1318-1321. 10.1038/nm.2053.PubMedCentralCrossRefPubMed
Metadata
Title
Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies
Authors
Chih Long Liu
Stephanie Tangsombatvisit
Jacob M Rosenberg
Gil Mandelbaum
Emily C Gillespie
Or P Gozani
Ash A Alizadeh
Paul J Utz
Publication date
01-02-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3707

Other articles of this Issue 1/2012

Arthritis Research & Therapy 1/2012 Go to the issue

Editorial

Abatacept versus other biologics in methotrexate inadequate responders with rheumatoid arthritis: you like tomato and I like tomahto... let's call the whole thing off

Research article

Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction

Research article

Takayasu's arteritis is associated with HLA-B*52, but not with HLA-B*51, in Turkey

Research article

The neuropeptide neuromedin U promotes autoantibody-mediated arthritis

Research article

Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine

Editorial

Autoimmunity induced by human cytomegalovirus in patients with systemic lupus erythematosus

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits